Background: Previous studies showed that alpha-1,2-fucosyltransferase (HT), decay accelerating factor (DAF), and CD59 have an inhibitory effect on the immunological rejection of xenogenic transplantation.
Methods: To investigate their possible synergistic effects in suppression of heterogeneic transplantation, we produced transgenic mouse lines expressing human HT, DAF, and/or CD59 by the standard pronuclear injection approach. PCR and Southern blot were used to identify the transgenic founder lines. Flow cytometry confirmed the high-level expression of HT, DAF, or CD59 in the transgenic mice.
Results: The deposition of IgM, C3c, or C9 in the cardiac vascular endothelial cells of the HT, HT/CD59, and/or DAF multiple positive transgenic mice was markedly decreased. The survival time and function of the hearts of the co-transgenic mice were significantly longer and higher than that of the single HT-positive transgenic mice (P < 0.05).
Conclusion: The mice co-expressing HT/DAF or HT/CD59 could resist the hyperacute rejection better than those expressing HT alone. It is feasible to use HT and C-reactive proteins co-transgenic tissues to resist hyperacute rejection and xenograft rejection.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1399-3089.2009.00509.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reduced decay-accelerating factor expression promotes complement-mediated cystogenesis in murine ADPKD.
JCI Insight
May 2024
Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Article Synopsis
- Patients with autosomal dominant polycystic kidney disease (ADPKD) exhibit complement activation, but its role in kidney cyst growth was previously unclear.
- Research using a specific cell line and genetically modified mice showed that lack of the Pkd1 gene leads to increased complement-related genes and faster cyst formation, while its absence delayed cyst growth and reduced inflammation.
- The study suggests that the downregulation of complement regulators due to Pkd1 loss enhances cystogenesis through C5a activation, indicating a potential new target for therapeutic interventions in ADPKD.
A 21-bp deletion in the complement regulator CD55 promotor region is associated with multifocal motor neuropathy and its disease course.
J Peripher Nerv Syst
June 2024
Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.
Background And Aims: To further substantiate the role of antibody-mediated complement activation in multifocal motor neuropathy (MMN) immunopathology, we investigated the distribution of promotor polymorphisms of genes encoding the membrane-bound complement regulators CD46, CD55, and CD59 in patients with MMN and controls, and evaluated their association with disease course.
Methods: We used Sanger sequencing to genotype five common polymorphisms in the promotor regions of CD46, CD55, and CD59 in 133 patients with MMN and 380 controls. We correlated each polymorphism to clinical parameters.
New insights into the immune functions of podocytes: the role of complement.
Mol Cell Pediatr
April 2023
Division of Nephrology, The Hospital for Sick Children, Toronto, ON, Canada.
Podocytes are differentiated epithelial cells which play an essential role to ensure a normal function of the glomerular filtration barrier (GFB). In addition to their adhesive properties in maintaining the integrity of the filtration barrier, they have other functions, such as synthesis of components of the glomerular basement membrane (GBM), production of vascular endothelial growth factor (VEGF), release of inflammatory proteins, and expression of complement components. They also participate in the glomerular crosstalk through multiple signalling pathways, including endothelin-1, VEGF, transforming growth factor β (TGFβ), bone morphogenetic protein 7 (BMP-7), latent transforming growth factor β-binding protein 1 (LTBP1), and extracellular vesicles.
View Article and Find Full Text PDFEffect of Heme Oxygenase-1 Depletion on Complement Regulatory Proteins Expression in the Rat.
Antioxidants (Basel)
December 2022
Veterans Affairs Medical Center and Virginia Tech, Carilion School of Medicine, Salem, VA 24153, USA.
Heme oxygenase has been implicated in the regulation of various immune responses including complement activation. Using a transgenic rat model of HO-1 depletion, the present study assessed the effect of HO-1 absence on the expression of complement regulatory proteins: decay accelerating factor (DAF), CR1-related gene/protein Y (Crry) and CD59, which act to attenuate complement activation. Protein expression was assessed by immunohistochemistry in kidney, liver, lung and spleen tissues.
View Article and Find Full Text PDFHemopexin Modulates Expression of Complement Regulatory Proteins in Rat Glomeruli.
Curr Issues Mol Biol
September 2021
Veterans Affairs Medical Center and Virginia Tech., Carilion School of Medicine, 1970 Roanoke Blvd, Salem, VA 24153, USA.
In systemic hemolysis and in hematuric forms of kidney injury, the major heme scavenging protein, hemopexin (HPX), becomes depleted, and the glomerular microvasculature (glomeruli) is exposed to high concentrations of unbound heme, which, in addition to causing oxidative injury, can activate complement cascades; thus, compounding extent of injury. It is unknown whether unbound heme can also activate specific complement regulatory proteins that could defend against complement-dependent injury. Isolated rat glomeruli were incubated in media supplemented with HPX-deficient (HPX) or HPX-containing (HPX) sera as a means of achieving different degrees of heme partitioning between incubation media and glomerular cells.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!